Homocysteine and other cardiovascular risk factors in patients with lichen planus

N Saleh1, N Samir, H Megahed

  • 1Department of Dermatology Faculty of Medicine, Cairo University, Cairo, Egypt.

Insights

Patients with lichen planus exhibit elevated cardiovascular and metabolic risk factors, including higher homocysteine and fibrinogen levels, likely due to chronic inflammation. This study highlights potential links between lichen planus and increased cardiovascular disease risk.

Area of Science:

  • Dermatology and Immunology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Chronic inflammation is implicated in cardiovascular risk factors.
  • Homocysteine and fibrinogen are independent cardiovascular disease risk factors.
  • Lichen planus is associated with dyslipidemia and potentially metabolic syndrome due to inflammatory cytokines.

Purpose of the Study:

  • To assess cardiovascular risk factors in lichen planus patients.
  • To investigate the relationship between lichen planus and metabolic syndrome parameters.

Main Methods:

  • Study included 40 lichen planus patients and 40 healthy controls.
  • Measured serum homocysteine, fibrinogen, and high-sensitive C-reactive protein (hs-CRP) using ELISA.
  • Evaluated metabolic syndrome parameters: anthropometrics, lipid profiles, blood sugar, and blood pressure.

Main Results:

  • Lichen planus patients showed significant metabolic syndrome associations (P < 0.001).
  • Elevated serum homocysteine, fibrinogen, and hs-CRP in lichen planus patients (P < 0.001).
  • Homocysteine correlated with hs-CRP and fibrinogen; fibrinogen showed a negative correlation with HDL.

Conclusions:

  • Lichen planus patients have increased metabolic and cardiovascular risk factors compared to controls.
  • Elevated risk factors are likely attributed to chronic inflammation associated with lichen planus.
  • Findings suggest lichen planus may be linked to heightened cardiovascular disease risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
757
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K